Carroll Investors’s Merck MRK Stock Holding History

Carroll Investors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-652	Closed	-$53K	–	113
2022 Q1	$53K	Hold	652	–	–	0.03%	72
2021 Q4	$48K	Buy	+652	New	+$51.9K	0.03%	96

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Carroll Investors's MRK Position: Q2 2022 in Review

Carroll Investors sold out of Merck (MRK) in Q2 2022, closing a stake of 652 shares — an estimated $53K sold.

Carroll Investors first reported a position in MRK in Q4 2021 and held it in 2 quarters. The position peaked at $53K in Q1 2022. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

Carroll Investors reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
Carroll Investors sold 652 Merck shares in Q2 2022, an estimated $53K.
Carroll Investors first reported a position in Merck in Q4 2021 and held it in 2 quarters.
Carroll Investors's Merck position peaked at $53K in Q1 2022.
3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Carroll Investors's 13F filing for Q2 2022, filed 26 Jul 2022.